Clinical Trial Update: Duration of Therapeutic Anticoagulation in Patients With Pulmonary Embolism

View source ↗

Summary

Clinical trial update investigating the optimal duration of therapeutic anticoagulation for patients with pulmonary embolism; study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Pulmonary Embolism | Status: RECRUITING